LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.001
53.04 27.76 4268 5365 0.7954 0.9406
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
53.04 27.76 2177 5365 0.4057 0.7760
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
53.04 27.76 4920 5365 0.9169 0.9773
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
54.74 27.76 4494 5606 0.8016 0.9431
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
54.74 27.76 4518 5606 0.8058 0.9444
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
54.74 27.76 2340 5606 0.4174 0.7843
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
54.74 27.76 5186 5606 0.9250 0.9797
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
56.45 27.76 4702 5745 0.8184 0.9486
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
56.45 27.76 4723 5745 0.8220 0.9497
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
56.45 27.76 2471 5745 0.4301 0.7923
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
56.45 27.76 5287 5745 0.9202 0.9785
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
58.15 27.76 4872 5906 0.8248 0.9508
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
58.15 27.76 4894 5906 0.8286 0.9520
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
58.15 27.76 2677 5906 0.4532 0.8055
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
58.15 27.76 5619 5906 0.9513 0.9871
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
59.85 27.76 5099 6062 0.8411 0.9559
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
59.85 27.76 5120 6062 0.8445 0.9570
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
59.85 27.76 2782 6062 0.4589 0.8092
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
59.85 27.76 5838 6062 0.9630 0.9903
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
61.56 27.76 5312 6217 0.8544 0.9601
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
61.56 27.76 5332 6217 0.8576 0.9610
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
61.56 27.76 2875 6217 0.4624 0.8119
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
61.56 27.76 6078 6217 0.9776 0.9942
MN20160318_Q01
M13
MCF 10A-H2B-mCherry Trametinib
0.001
63.26 27.76 5468 6465 0.8457 0.9578
MN20160318_Q01
H11
MCF 10A-H2B-mCherry Trametinib
0.001
63.26 27.76 5491 6465 0.8493 0.9589
MN20160318_Q01
H11